1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Branded Generics Market – By Therapeutic Application

1.3.2        APAC Branded Generics Market – By Distribution Channel

1.3.3        APAC Branded Generics Market – By Drug Class

1.3.4        APAC Branded Generics Market – By Formulation Type

1.3.5        APAC Branded Generics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Branded Generics Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.2.1        Experts Opinion

5.           APAC Branded Generics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Branded Generics Becoming Popular

5.1.2        Branded Generics Being Promoted by Various Government Initiatives

5.2         Market Restraints

5.2.1        Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications

5.3         Market Opportunities

5.3.1        Product Differentiation Providing New Opportunities

5.4         Future Trends

5.4.1        Encouraging Utility of Branded Generics by Healthcare Providers and Professionals

5.5         Impact Analysis

6.           Branded Generics Market– APAC Analysis

6.1         APAC Branded Generics Market Revenue Forecast and Analysis

6.2         APAC Branded Generics Market, By Country - Forecast and Analysis

7.           APAC Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application

7.1         Overview

7.2         APAC Branded Generics Market, By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)

7.3         Oncology

7.3.1        Overview

7.3.2        Oncology Market Revenue and Forecast to 2028 (US$ Billion)

7.4         Cardiovascular Diseases

7.4.1        Overview

7.4.2        Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.5         Diabetes

7.5.1        Overview

7.5.2        Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

7.6         Neurology

7.6.1        Overview

7.6.2        Neurology Market Revenue and Forecast to 2028 (US$ Billion)

7.7         Gastrointestinal Diseases

7.7.1        Overview

7.7.2        Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.8         Dermatology Diseases

7.8.1        Overview

7.8.2        Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.9         Analgesics and Anti-Inflammatory

7.9.1        Overview

7.9.2        Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

7.10      Others

7.10.1     Overview

7.10.2     Others Market Revenue and Forecast to 2028 (US$ Billion)

8.           APAC Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel

8.1         APAC Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

8.2         Hospital Pharmacies

8.2.1        Overview

8.2.2        Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.3         Retail Pharmacies

8.3.1        Overview

8.3.2        Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.4         Online Pharmacies

8.4.1        Overview

8.4.2        Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.5         Drug Stores

8.5.1        Overview

8.5.2        Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.           APAC Branded Generics Market Analysis and Forecast to 2028 by Drug Class

9.1         APAC Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

9.2         Alkylating Agents

9.2.1        Overview

9.2.2        Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.3         Antimetabolites

9.3.1        Overview

9.3.2        Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.4         Hormones

9.4.1        Overview

9.4.2        Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.5         Anti-hypertensive

9.5.1        Overview

9.5.2        Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.6         Lipid Lowering Drugs

9.6.1        Overview

9.6.2        Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.7         Anti-Depressants

9.7.1        Overview

9.7.2        Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.8         Anti-psychotics

9.8.1        Overview

9.8.2        Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.9         Anti-epileptic

9.9.1        Overview

9.9.2        Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.10      Others

9.10.1     Overview

9.10.2     Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

10.        APAC Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type

10.1      Overview

10.2      APAC Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

10.3      Oral

10.3.1     Overview

10.3.2     Oral Market Revenue and Forecast to 2028 (US$ Billion)

10.4      Parenteral

10.4.1     Overview

10.4.2     Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

10.5      Topical

10.5.1     Overview

10.5.2     Topical Market Revenue and Forecast to 2028 (US$ Billion)

10.6      Others

10.6.1     Overview

10.6.2     Others Market Revenue and Forecast to 2028 (US$ Billion)

11.        APAC Branded Generics Market Revenue and Forecasts to 2028 Country Analysis

11.1      Overview

11.1.1     APAC: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1       Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.1.1       Overview

11.1.1.1.2       Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.1.3       Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.1.4       Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.1.5       Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.6       Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2       China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.2.1       Overview

11.1.1.2.2       China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.2.3       China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.2.4       China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.2.5       China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.6       China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3       India Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.3.1       Overview

11.1.1.3.2       India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.3.3       India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.3.4       India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.3.5       India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.6       India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4       South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.4.1       Overview

11.1.1.4.2       South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.4.3       South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.4.4       South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.4.5       South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.6       South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5       Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.5.1       Overview

11.1.1.5.2       Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.5.3       Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.5.4       Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.5.5       Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.6       Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6       Rest of APAC: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of APAC: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.3       Rest of APAC: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.6.4       Rest of APAC: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.6.5       Rest of APAC: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.6       Rest of APAC: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

12.        Branded Generics Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      MYLAN N.V.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bausch Health Companies Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Lupin

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Sanofi

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      ASTRAZENECA PLC.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Dr. Reddy's Laboratories

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Par Pharmaceuticals, INC

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Sandoz International GMBH

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Aspen Holdings

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

13.12   Hetero

13.12.1  Key Facts

13.12.2  Business Description

13.12.3  Products and Services

13.12.4  Financial Overview

13.12.5  SWOT Analysis

13.12.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 2.             Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 3.             Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 4.             Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 5.             China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 6.             China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 7.             China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 8.             China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 9.             India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 10.          India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 11.          India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 12.          India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 13.          South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 14.          South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 15.          South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 16.          South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 17.          Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 18.          Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 19.          Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 20.          Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 21.          Rest of APAC: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 22.          Rest of APAC: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 23.          Rest of APAC: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 24.          Rest of APAC: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done By Companies

Table 27.          Glossary of Terms

LIST OF FIGURES

Figure 1.           APAC Branded Generics Market Segmentation

Figure 2.           APAC Branded Generics Market, By Country

Figure 3.           APAC Branded Generics Market Overview

Figure 4.           Others Segment Held Largest Share of Drug Class Segment in APAC Branded Generics Market

Figure 5.           India is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           APAC: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints on APAC Branded Generics Market

Figure 9.           APAC Branded Generics Market – By Country Forecast and Analysis – 2019 - 2028

Figure 10.        APAC Branded Generics Market, By Therapeutic Application: Market Analysis and Forecast 2022 and 2028 (%)

Figure 11.        APAC Oncology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 12.        APAC Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 13.        APAC Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

Figure 14.        APAC Neurology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 15.        APAC Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 16.        APAC Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 17.        APAC Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

Figure 18.        APAC Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 19.        APAC Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

Figure 20.        APAC Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 21.        APAC Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 22.        APAC Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 23.        APAC Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 24.        APAC Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

Figure 25.        APAC Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 26.        APAC Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 27.        APAC Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 28.        APAC Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 29.        APAC Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 30.        APAC Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 31.        APAC Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 32.        APAC Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 33.        APAC Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 34.        APAC Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

Figure 35.        APAC Oral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 36.        APAC Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 37.        APAC Topical Market Revenue and Forecast to 2028 (US$ Billion)

Figure 38.        APAC Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 39.        APAC Branded Generics Market Overview, by Country (2022)

Figure 40.        APAC: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

Figure 41.        Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 42.        China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 43.        India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 44.        South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 45.        Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 46.        Rest of APAC: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 47.        Growth Strategies Done by the Companies in the Market (%)